Swiss authorities have postponed the start of its mass swine
flu vaccination campaign until the beginning of December reports
the Neue Zürcher Zeitung.

The newspaper reports that some authorities are sending out letters
to staff telling them that the vaccine campaign has been delayed
until December because pharma companies cannot deliver enough
vaccines.

The report comes at a time of growing concern over the safety
of GlaxoSmithKline's
Pandemrix swine flu jab and Novartis's Celtura jab, which
was unexpectedly not given market approval by the Swiss drug regulator
Swissmedic last week over safety data and contamination worries.

A Swiss Health Ministry spokesperon Jean-Louis Zürcher,
however, told the NZZ that the information about the postponement
of the swine flu campaign "was not quite true" and that
pharma companies had plenty of vaccine, fuelling the impression
that there are growing divisions over the need and timing of mass
"swine flu" jab campaign within Switzerland.